Cargando…

Peroxiporin Expression Is an Important Factor for Cancer Cell Susceptibility to Therapeutic H(2)O(2): Implications for Pharmacological Ascorbate Therapy

Cancer cell toxicity to therapeutic H(2)O(2) varies widely depending on cell type. Interestingly, it has been observed that different cancer cell types have varying peroxiporin expression. We hypothesize that variation in peroxiporin expression can alter cell susceptibility to therapeutic H(2)O(2) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erudaitius, Dieanira, Huang, Andrew, Kazmi, Sarah, Buettner, Garry R., Rodgers, Victor G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249139/ https://www.ncbi.nlm.nih.gov/pubmed/28107421 http://dx.doi.org/10.1371/journal.pone.0170442

Ejemplares similares

Peroxiporins in Cancer
por: Prata, Cecilia, et al.
Publicado: (2019)

Tumor cells have decreased ability to metabolize H(2)O(2): Implications for pharmacological ascorbate in cancer therapy
por: Doskey, Claire M., et al.
Publicado: (2016)

The role of mitochondria in pharmacological ascorbate-induced toxicity
por: Du, Juan, et al.
Publicado: (2022)

Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H(2)O(2)-Dependent Manner
por: Heer, Collin D., et al.
Publicado: (2018)

In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs
por: Musser, Margaret L., et al.
Publicado: (2019)

Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer()
por: Moser, Justin C., et al.
Publicado: (2013)

Redox active metals and H(2)O(2) mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models()
por: Schoenfeld, Joshua D., et al.
Publicado: (2017)

Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
por: Du, Juan, et al.
Publicado: (2021)

Peroxiporins Are Induced upon Oxidative Stress Insult and Are Associated with Oxidative Stress Resistance in Colon Cancer Cell Lines
por: Čipak Gašparović, Ana, et al.
Publicado: (2021)

Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
por: Wagner, Brett A., et al.
Publicado: (2023)

Utilization of Pharmacological Ascorbate to Enhance Hydrogen Peroxide-Mediated Radiosensitivity in Cancer Therapy
por: Mehdi, Zain, et al.
Publicado: (2021)

Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2023)

Ascorbate mediates the non-enzymatic reduction of nitrite to nitric oxide
por: Du, Juan, et al.
Publicado: (2023)

Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
por: Aguilar-Rivera, Marcelo, et al.
Publicado: (2020)

BIMG-07. PHARMACOLOGICAL ASCORBATE ENHANCES RADIATION AND TEMOZOLOMIDE EFFECTIVENESS IN GLIOBLASTOMA BY A MECHANISM MEDIATED BY REDOX ACTIVE IRON
por: Allen, Bryan, et al.
Publicado: (2021)

The rate of cellular hydrogen peroxide removal shows dependency on GSH: Mathematical insight into in vivo H(2)O(2) and GPx concentrations
por: Ng, Chin F., et al.
Publicado: (2007)

Inhibition of thioredoxin-dependent H(2)O(2) removal sensitizes malignant B-cells to pharmacological ascorbate
por: Graczyk-Jarzynka, Agnieszka, et al.
Publicado: (2018)

Epigenetic effects of pharmacologic ascorbate
por: Steers, Garett J., et al.
Publicado: (2021)

Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells
por: Brandt, Kristin E., et al.
Publicado: (2017)

Therapeutic Approach of KRAS Mutant Tumours by the Combination of Pharmacologic Ascorbate and Chloroquine
por: Kapuy, Orsolya, et al.
Publicado: (2021)

Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
por: Zaher, Amira, et al.
Publicado: (2022)

Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma
por: Witmer, Jordan R., et al.
Publicado: (2016)

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo
por: Niessner, Heike, et al.
Publicado: (2022)

Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter
por: Violet, Pierre-Christian, et al.
Publicado: (2017)

The Role of H(2)O(2)-Scavenging Enzymes (Ascorbate Peroxidase and Catalase) in the Tolerance of Lemna minor to Antibiotics: Implications for Phytoremediation
por: Gomes, Marcelo Pedrosa, et al.
Publicado: (2022)

Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2022)

Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer
por: Furqan, Muhammad, et al.
Publicado: (2022)

Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate
por: Petronek, M.S., et al.
Publicado: (2023)

Observations of Ascorbic Acid. Part XI. Therapeutic Effect of Ascorbic Acid in Tuberculosis
por: Babbar, Inder Jit
Publicado: (1948)

Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy
por: Cushing, Cameron M., et al.
Publicado: (2020)

Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications
por: Kontoghiorghes, George J., et al.
Publicado: (2020)

The dual effect of pharmacological ascorbate on radiation: The best of both worlds
por: Cullen, Joseph J.
Publicado: (2018)

Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH(-))
por: Zhang, Xuan, et al.
Publicado: (2019)

Pharmacological Modulations of Nrf2 and Therapeutic Implications in Aneurysmal Subarachnoid Hemorrhage
por: Zhang, Qia, et al.
Publicado: (2023)

Potential Antitumor Activity of 2-O-α-d-Glucopyranosyl-6-O-(2-Pentylheptanoyl)-l-Ascorbic Acid
por: Miura, Kaori, et al.
Publicado: (2018)

Band Gap Implications on Nano-TiO(2) Surface Modification with Ascorbic Acid for Visible Light-Active Polypropylene Coated Photocatalyst
por: D’Amato, Chiara Anna, et al.
Publicado: (2018)

3-O-Ethyl-l-ascorbic acid
por: Jin, Shu, et al.
Publicado: (2008)

2-O-Acyl-3-O-(1-acyloxyalkyl) Prodrugs of 5,6-Isopropylidene-l-Ascorbic Acid and l-Ascorbic Acid: Antioxidant Activity and Ability to Permeate Silicone Membranes
por: Thiele, Nikki A., et al.
Publicado: (2016)

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid
por: Xia, Jiliang, et al.
Publicado: (2017)

Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients
por: Bolaman, Ali Zahit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1nibfc39o5rgdv8c0lqna3fbf